logo
Has Trump declared you dead? You won't enjoy it if he does.

Has Trump declared you dead? You won't enjoy it if he does.

The Hill17-04-2025
Last Thursday, The Trump administration placed 6,300 immigrants on Social Security's 'Death Master File.' According to Nancy Altman, president of Social Security Works, being listed there means 'losing your income, your health insurance, access to your bank account, your credit cards, your home, and more.'
And that is precisely the administration's goal: to find people it doesn't like and compel them to leave. It claimed, without proof, that the people they declared dead are criminals or suspected terrorists. The claim is questionable, since the list includes eight children.
So far, the only apparent commonality among the targets is that they were granted legal status during the previous administration. That's right — they are here legally. They followed the process to obtain Social Security numbers and were permitted to remain in the U.S. and work. The new administration, however, has reneged on that commitment and wants them to self-deport.
For the Trump team, commitments made by our institutions can be invalidated based on the subjective judgment of a single individual. Process doesn't matter. The law doesn't matter. The only requirement for being declared dead is your esteem in the minds of those who control the data. If that's the deciding factor, why wouldn't any of the rest of us be next?
The consequences of being on the Death Master List are dire. This affects a lot more than eligibility for Social Security benefits. Presence on the list sets in motion credit card cancellations and home loan foreclosures. It ends access to insured medical care. It means that you cannot work or apply for an apartment or open a bank account.
For example, one elderly woman who was inadvertently placed on the list in December 2023 died after months of trying to correct the error. For months, she went without the income she relied on. Her home was listed for sale and her medical insurance was cancelled, leaving her unable to afford life-saving medication. At 88, she died from the stress and consequences of being already categorized as dead. (Her family has sued the Social Security Administration earlier this month.)
If you are placed on this list — deliberately or mistakenly — you no longer exist, according to the institutional engines of our country. You may be alive, but your life will be plagued with irreversible consequences.
Who among us will be next to be economically exiled? Are you a doctor who performs abortions? A journalist who publishes unflattering articles? An attorney who has represented an adversary? Members of these classes have already been subject to harassing lawsuits by Trump or his associates. Are you gay? Muslim? A Tesla protester? All of these classes have been targets of the administration's verbal wrath.
Beyond lawsuits and threats, the administration has already punished foreign nationals residing in the U.S. by rescinding visas and deporting them without due process. And on April 14, in an Oval Office meeting with the president of El Salvador, who is being paid to imprison deportees, Trump announced that he is willing to apply his deportation tactics to American citizens as well.
'We also have homegrown criminals that push people into subways … that are absolute monsters,' Trump said. 'I'd like to include them … to get them out of the country,' he continued.
But we know violent behavior is not the real criterion. Trump's ease in pardoning Jan. 6 rioters, some of whom violently assaulted police officers, proves that it's his personal assessment that is the driving factor in who is punished and who is not.
This newest deportation weapon is an efficient means of delivering that punishment. It's swift, deadly and requires little effort. A simple digital switch can eviscerate an entire existence. Further, there has been little resistance to any of the administration's tactics, so implementation has been frictionless.
The Republican-led Congress has not voiced objection or attempted to protect residents through legislation. And the Supreme Court recently issued what sounds more like a suggestion than a ruling to return a wrongfully deported resident. Add to that the administration's overt defiance of lower court rulings, without consequence, and its path to deporting anyone it deems worthy seems unobstructed.
Criminal or not, citizen or not, we are all at risk.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Why Investors Were So Fired Up About First Solar Stock on Friday
Why Investors Were So Fired Up About First Solar Stock on Friday

Yahoo

time15 minutes ago

  • Yahoo

Why Investors Were So Fired Up About First Solar Stock on Friday

Key Points Data center operators are unhappy with potential changes to federal incentives for green energy solutions. A group of them are lobbying the Trump administration to leave these incentives alone for now. 10 stocks we like better than First Solar › The solar industry has struggled mightily for years to achieve meaningful growth and post net profits. During the Biden administration, the green energy sector as a whole received something of a break in the 2022 Inflation Reduction Act, with a slew of tax incentives for building out alternative-energy solutions. In its attempt to reverse this, President Donald Trump has tasked his administration to make the current subsidies harder to obtain. Thankfully for green energy companies, a theoretically influential lobbying group stepped in on Friday to push back against this effort. Numerous solar stocks popped on the news, including First Solar (NASDAQ: FSLR), which rose a sturdy 11% by market close. A mighty lob by a lobbying group The business grouping behind Friday's pushback is the Data Center Coalition. News broke that the coalition sent a formal request to Treasury Secretary Scott Bessent to maintain the subsidy policy as it is, rather than changing it. The organization -- which lists as members Amazon, Oracle, and CoreWeave, among other prominent tech companies -- told Bessent that any regulatory roadblock limiting green energy solutions will hamper the development of artificial intelligence (AI). Many data center operators are currently building out their facilities to handle the vastly increased resource demands of AI. To do so, they require more energy, hence their support of renewable sources like solar. Does the silence speak volumes? Bessent hasn't yet publicly responded to the coalition's lobbying effort, nor has anyone else in the Trump administration. But investors seem convinced that they've not only digested the letter, they're taking it seriously, since the organization behind it has many prominent members who drive the U.S. economy. Should you invest $1,000 in First Solar right now? Before you buy stock in First Solar, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and First Solar wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $663,630!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,115,695!* Now, it's worth noting Stock Advisor's total average return is 1,071% — a market-crushing outperformance compared to 185% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of August 13, 2025 Eric Volkman has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Amazon, First Solar, and Oracle. The Motley Fool has a disclosure policy. Why Investors Were So Fired Up About First Solar Stock on Friday was originally published by The Motley Fool

China's Biotech Is Cheaper and Faster
China's Biotech Is Cheaper and Faster

New York Times

time34 minutes ago

  • New York Times

China's Biotech Is Cheaper and Faster

Just outside of Shanghai, in the city of Wuxi, China is building its future of medicine — a booming biotechnology hub of factories and laboratories where global pharmaceutical companies can develop and manufacture drugs faster and cheaper than anywhere else. Amid the Trump administration's tariffs on China, I figured manufacturing hubs like this one would be wracked with anxiety. But when I visited Wuxi in April, government officials insisted that its research hub was flourishing. They were proud to tell me about their superstar labs and companies that are continuing to thrive. The fact that Chinese biotechnology stocks have surged over 60 percent since January seems to bolster this claim. The city's researchers certainly seemed positioned to be busy for decades. In its quest to dethrone American dominance in biotech, China isn't necessarily trying to beat America at its own game. While the U.S. biotech industry is known for incubating cutting-edge treatments and cures, China's approach to innovation is mostly focused on speeding up manufacturing and slashing costs. The idea isn't to advance, say, breakthroughs in the gene-editing technology CRISPR; it's to make the country's research, development, testing and production of drugs and medical products hyperefficient and cheaper. As a result, China's biotech sector can deliver drugs and other medical products to customers at much cheaper prices, including inexpensive generics. These may not be world-changing cures, but they are treatments that millions of people around the world rely on every day. And as China's reach expands, the world will soon have to reckon with a new leader in biotech and decide how it wants to respond. One such company that embodies the Chinese approach to biotech is Wuxi AppTec. It's a one-stop shop for pharmaceutical research and development, streamlining everything from early-stage drug discovery to young scientist recruitment and medication production. The company, whose clients have included Chinese firms like Innovent and Jiangsu Hengrui, as well as American and European drugmakers like Pfizer, GlaxoSmithKline and AstraZeneca, was involved in, by one estimate, a quarter of the drugs used in the United States, including blockbuster cancer drugs. Though the Chinese government bargains hard with both foreign and domestic pharmaceutical companies to provide products at the right price in exchange for market access, the low prices that Chinese consumers pay are ultimately the result of Chinese biotech companies' ability to test and manufacture drugs at a pace far faster than their American counterparts. So far, American biotech giants don't seem to mind the competition, since their own use of companies like Wuxi AppTec allows them to dedicate more of their money to breakthrough research. Want all of The Times? Subscribe.

Ukrainian sniper breaks world record with 13,000-foot kill shot against Russian forces: report
Ukrainian sniper breaks world record with 13,000-foot kill shot against Russian forces: report

New York Post

timean hour ago

  • New York Post

Ukrainian sniper breaks world record with 13,000-foot kill shot against Russian forces: report

A Ukrainian sniper unit on Thursday reportedly broke the world record for the longest confirmed sniper kill, eliminating Russian troops from a distance of more than 13,000 feet. The shot, fired by a Ukrainian-produced rifle and aided by artificial intelligence and drone guidance, left two Russian soldiers dead in the area of Pokrovsk, Ukraine, the Kyiv Post reported. 'The record-breaking shot was made on Aug. 14, 2025, using artificial intelligence under the guidance of [an unmanned aerial vehicle] complex with a 14.5 mm alligator rifle,' said military journalist Yuri Butusov, according to the Kyiv Post. The shooting took place amid increased Russian attacks in the area surrounding Pokrovsk, which was once a city with more than 60,000 residents, the Post reported. The previous world record belonged to a 58-year-old Ukrainian sniper who eliminated a target from a distance of around 12,400 feet, the outlet added. The record-breaking shot reportedly took place a day before President Donald Trump's closely-watched summit Friday with Russian President Vladimir Putin. 3 A Ukrainian soldier in the sniper unit of the 108th Territorial Defense Brigade readies a rifle during training on Nov. 4, 2023. Anadolu via Getty Images 3 The previous world record was held by another Ukrainian sniper who took out a Russian soldier from nearly 2½ miles away with a high-tech rifle known as 'Horizon's Lord.' SBU 3 Ukrainian soldiers take part in a sniper shooting exercise at a training facility outside Kyiv on Nov. 21, 2023. AFP via Getty Images Putin, who spoke first in a joint press conference held by the two world leaders, described the talks as a 'constructive atmosphere of mutual respect.' Ukrainian President Volodymyr Zelensky is scheduled to meet with Trump in Washington, DC, Monday. Zelensky said in a post on X that he and Trump will 'discuss all of the details regarding ending the killing and the war.'

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store